삼성서울병원

Ko En

진단검사의학과 조덕 교수

진료분야
수혈의학, 유세포학
진료일정 04 月
날짜
01
02
03
04
05
06
07
08
09
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
오전
오후
진료일정 05 月
날짜
01
02
03
04
05
06
07
08
09
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
오전
오후

학력

학력
2003.02 전남대학교 대학원 의학과(박사)
1996.02 전남대학교 대학원 의학과(석사)
1993.02 전남대학교 의과대학 졸업(의학사)

경력

경력
2015.03 ~현재 삼성서울병원, 성균관의대 진단검사의학과 교수
2014.03 ~ 2015.02 화순전남대병원 진단검사의학과 과장
2006.03 ~ 2015.02 전남대학교 조교수& 부교수
2007.04 ~ 2009.05 미국 St Jude Children Research Hospital (NK cell immunotherapy) 연수
2001.03 ~ 2006.02 전남대학교병원 전임의사, 전임강사, 조교수
1998.03 ~ 2001.02 전방 군의관 및 국군수도병원 병리시험과 과장
1993.03 ~ 1998.02 전남대학교병원 인턴 및 진단검사의학과 레지던트

학회활동

학회활동
International Clinical Cytometry Society, 회원
Society for Natural Immunity, 회원
국제수혈학회 정회원
대한수혈학회 정회원, 대한수혈학회지 편집위원장
대한진단검사의학회 정회원, ALM 편집위원
대한혈액학회 정회원, Blood Res 편집위원

수상이력

수상이력
2023.12 산업통상자원부장관상
2023.11 보건복지부장관상
2020.10 대한진단검사의학회 우수연구자상
2018.06 보건복지부장관상
2017.06 질병관리본부장상
2016.10 2016 대한적십자사총재상
2006.05 과학기술우수논문상 수상
  • ANN LAB MED 2023 10.3343/alm.2023.43.6.635 ABO Blood Group Antigen Changes in Acute Myeloid Leukemia and No Significant Association With RUNX1 and GATA2 Somatic Variants Jeong, IH; Seo, JY; Choi, S; Kim, HY; Cho, DC
    View PubMed
  • TRANSFUSION 2023 10.1111/trf.17608 Prevalence and molecular basis of null blood group phenotypes in the Korean population: Analysis using a public database Kim, TY; Park, MS; Jang, JH; Woo, HY; Cho, D
    View PubMed
  • CANCER IMMUNOL IMMUN 2023 10.1007/s00262-023-03545-w Intensified NK cell therapy in combination with low-dose chemoradiotherapy against human colorectal cancer Nguyen, HPQ; Bae, WK; Park, MS; Chung, IJ; Nam, TK; Jeong, JU; Uong, TNT; Cho, DC; Kim, SK; Yoon, M
    View PubMed
  • ANN LAB MED 2023 10.3343/alm.2023.43.5.477 Reducing Microbial Contamination in Hematopoietic Stem Cell Products and Quality Improvement Strategy: Retrospective Analysis of 1996-2021 Data Ko, YK; Lee, JK; Park, HK; Han, AK; Mun, SK; Park, HJ; Choung, HK; Kim, SM; Choi, KM; Lee, NY; Cho, DC; Kim, DW; Kang, ES
    View PubMed
  • NANO LETT 2023 10.1021/acs.nanolett.3c01720 Genetically Stable and Scalable Nanoengineering of Human Primary T Cells via Cell Mechanoporation Hur, J; Kim, H; Kim, U; Kim, GB; Kim, J; Joo, B; Cho, DC; Lee, DS; Chung, AJ
    View PubMed
  • SCI REP-UK 2023 10.1038/s41598-023-36200-6 Comparison of the different anti-CD16 antibody clones in the activation and expansion of peripheral blood NK cells Kim, J; Phan, MT; Hwang, I; Park, J; Cho, D
    View PubMed
  • SMALL 2023 10.1002/smll.202302809 Integrative Magneto-Microfluidic Separation of Immune Cells Facilitates Clinical Functional Assays Shin, HS; Park, J; Lee, SY; Yun, HG; Kim, B; Kim, J; Han, SB; Cho, DC; Doh, J; Choi, S
    View PubMed
  • ANN LAB MED 2023 10.3343/alm.2023.43.3.310 The First Case of Acute Myeloid Leukemia With t(10;11)(p13;q21);PICALM-MLLT10 Rearrangement Presenting With Extensive Skin Involvement Park, MS; Kim, HY; Lee, JJ; Cho, DC; Jung, CW; Kim, HJ; Kim, SH
    View PubMed
  • ANN LAB MED 2023 10.3343/alm.2023.43.2.204 The First Case of Acute Myeloid Leukemia With Underlying Fanconi Anemia due to FANCF Variants Suh, E; Shin, S; Ju, HY; Yoo, KH; Kim, HY; Cho, DC; Kim, SH; Kim, HJ
    View PubMed
  • J IMMUNOTHER CANCER 2023 10.1136/jitc-2022-006130 Synergistic therapeutic combination with a CAF inhibitor enhances CAR-NK-mediated cytotoxicity via reduction of CAF-released IL-6 Lee, YE; Go, GY; Koh, EY; Yoon, HN; Seo, M; Hong, SM; Jeong, JH; Kim, JC; Cho, D; Kim, TS; Kim, SC; Jun, E; Jang, M
    View PubMed
  • FRONT ONCOL 2023 10.3389/fonc.2022.1071281 Real-world experiences of CNS-directed chemotherapy followed by autologous stem cell transplantation for secondary CNS involvement in relapsed or refractory diffuse large B-cell lymphoma Jeong, SY; Yoon, SE; Cho, D; Kang, ES; Cho, J; Kim, WS; Kim, SJ
    View PubMed
  • CANCER RES TREAT 2023 10.4143/crt.2022.017 Circulating Tumor DNA-Based Genotyping and Monitoring for Predicting Disease Relapses of Patients with Peripheral T-Cell Lymphomas Kim, SJ; Kim, YJ; Yoon, SE; Ryu, KJ; Park, B; Park, D; Cho, D; Kim, HY; Cho, J; Ko, YH; Park, WY; Kim, WS
    View PubMed
  • ANN LAB MED 2023 10.3343/alm.2023.43.1.124 Allelic Enhancement of BEL.02 With the Single Nucleotide Variant, c.669G>T Bae, GE; Kim, TY; Yu, H; Seo, JY; Suh, JS; Chang, SH; Cho, D
    View PubMed
  • TRANSFUSION 2022 10.1111/trf.17153 Detection of unexpected antibodies in Korean multiple myeloma patients on daratumumab using dithiothreitol-treated reagent cells is more efficient than extended phenotyping and genotyping Jeong, IH; Seo, JY; Kim, TY; Cho, D
    View PubMed
  • ANN LAB MED 2022 10.3343/alm.2022.42.6.638 Natural Killer Cell Expansion and Cytotoxicity Differ Depending on the Culture Medium Used Koh, SK; Park, J; Kim, SE; Lim, Y; Phan, MTT; Kim, J; Hwang, I; Ahn, YO; Shin, S; Doh, J; Cho, D
    View PubMed
  • CANCER IMMUNOL IMMUN 2022 10.1007/s00262-022-03322-1 Expanded natural killer cells potentiate the antimyeloma activity of daratumumab, lenalidomide, and dexamethasone in a myeloma xenograft model Thangaraj, JL; Jung, SH; Vo, MC; Chu, TH; Phan, MTT; Lee, KH; Ahn, SY; Kim, M; Song, GY; Ahn, JS; Yang, DH; Kim, HJ; Cho, D; Lee, JJ
    View PubMed
  • ANN LAB MED 2022 10.3343/alm.2022.42.5.558 Clinical Utility of Next-Generation Flow-Based Minimal Residual Disease Assessment in Patients with Multiple Myeloma Kim, HY; Yoo, IY; Lim, DJ; Kim, HJ; Kim, SH; Yoon, SE; Kim, SJ; Cho, D; Kim, K
    View PubMed
  • INT J MOL SCI 2022 10.3390/ijms23169426 Selective Expansion of NKG2C+Adaptive NK Cells Using K562 Cells Expressing HLA-E Phan, MTT; Kim, J; Koh, SK; Lim, Y; Yu, H; Lee, M; Lee, JM; Kang, ES; Kim, HY; Kim, SK; Hwang, I; Cho, D
    View PubMed
  • CYTOTHERAPY 2022 10.1016/j.jcyt.2022.05.004 Natural killer cells have a synergistic anti-tumor effect in combination with chemoradiotherapy against head and neck cancer Jung, EK; Chu, TH; Vo, MC; Nguyen, HPQ; Lee, DH; Lee, JK; Lim, SC; Jung, SH; Yoon, TM; Yoon, MS; Cho, D; Lee, JJ; Cho, HH
    View PubMed
  • AM J CLIN PATHOL 2022 10.1093/ajcp/aqac002 Rh(D) Alloimmunization Risk After Rh(D)-Incompatible Solid Organ Transplantations in Rh(D)-Negative Recipients Ahn, A; Yang, JJ; Youk, HJ; Cho, D; Oh, HB; Ko, DH; Hwang, SH
    View PubMed
  • CANCER RES TREAT 2022 10.4143/crt.2021.752 Plasma Circulating Tumor DNA in Patients with Primary Central Nervous System Lymphoma Yoon, SE; Kim, YJ; Shim, JH; Park, D; Cho, J; Ko, YH; Park, WY; Mun, YC; Lee, KE; Cho, D; Kim, WS; Kim, SJ
    View PubMed
  • TRANSFUSION 2022 10.1111/trf.16678 A variant allele with c.467C > T and c.784G > A is not a novel allele but ABO*AW10 Nam, M; Kim, TY; Hur, M; Cho, D
    View PubMed
  • BONE MARROW TRANSPL 2022 10.1038/s41409-022-01605-w Role of upfront autologous stem cell transplantation in patients newly diagnosed with primary CNS lymphoma treated with R-MVP: real-world data from a retrospective single-center analysis Yoon, SE; Jo, H; Kang, ES; Cho, D; Cho, J; Kim, WS; Kim, SJ
    View PubMed
  • TRANSFUS APHER SCI 2021 10.1016/j.transci.2021.103230 Analysis of ABO grouping discrepancies among patients from a tertiary hospital in Korea Heo, WY; Chung, YN; Kim, TY; Yu, HB; Bae, JC; Kim, H; Cho, D
    View PubMed
  • ANN LAB MED 2021 10.3343/alm.2021.41.6.598 Aberrant Loss of Surface CD3 and TCR gamma delta Expression in Relapsed Hepatosplenic T-cell Lymphoma Lee, B; Lim, DJ; Heo, WY; Yoon, SE; Kim, HY; Kim, HJ; Kim, SH; Cho, D
    View PubMed
  • TRANSFUSION 2021 10.1111/trf.16730 Molecular basis of weak A subgroups in the Korean population: Identification of three novel subgroup-causing variants in the ABO regulatory regions Kim, TY; Yu, HB; Seo, JY; Cho, D
    View PubMed
  • TRANSPL IMMUNOL 2021 10.1016/j.trim.2021.101484 Hyperacute rejection in ABO-incompatible kidney transplantation: Significance of isoagglutinin subclass Yang, JJ; Baek, CH; Kim, H; Kwon, H; Shin, S; Kim, YH; Hwang, SH; Oh, HB; Park, SK; Cho, D; Ko, DH
    View PubMed
  • FRONT IMMUNOL 2021 10.3389/fimmu.2021.733317 High-Throughput 3D In Vitro Tumor Vasculature Model for Real-Time Monitoring of Immune Cell Infiltration and Cytotoxicity Song, J; Choi, H; Koh, SK; Park, D; Yu, J; Kang, H; Kim, Y; Cho, D; Jeon, NL
    View PubMed
  • ANN LAB MED 2021 10.3343/alm.2021.41.5.493 ABO-Incompatible Transfusion Events Reported in Written Judgments and in the Korean Hemovigilance System Choi, S; Hyun, J; Yu, H; Cho, D
    View PubMed
  • VOX SANG 2021 10.1111/vox.13207 Sequence variants in the proximal promoter and+5.8-kb site of ABO in Koreans with weak B phenotypes Yu, H; Kim, TY; Moon, SJ; Chung, YN; Yoo, HJ; Kim, JH; Cho, D
    View PubMed
  • TRANSFUS MED HEMOTH 2021 10.1159/000517565 Application of Blood Group Genotyping by Next-Generation Sequencing in Various Immunohaematology Cases Kim, TY; Yu, HB; Phan, MTT; Jang, JH; Cho, D
    View PubMed
  • J CLIN APHERESIS 2021 10.1002/jca.21924 Correlation between peripheral blood automated hematopoietic progenitor cell counts and flow cytometric CD34(+) cell counts differs according to diagnosis in patients undergoing autologous peripheral blood stem cell transplantation Kim, SM; Kim, HY; Kim, SJ; Jang, JH; Kim, K; Kim, WS; Jung, CW; Cho, D; Kang, ES
    View PubMed
  • CANCER IMMUNOL IMMUN 2021 10.1007/s00262-021-02982-9 Expansion of cytotoxic natural killer cells in multiple myeloma patients using K562 cells expressing OX40 ligand and membrane-bound IL-18 and IL-21 Thangaraj, JL; Phan, MTT; Kweon, S; Kim, J; Lee, JM; Hwang, I; Park, J; Doh, J; Lee, SH; Vo, MC; Chu, TH; Song, GY; Ahn, SY; Jung, SH; Kim, HJ; Cho, D; Lee, JJ
    View PubMed
  • BLOOD TRANSFUS-ITALY 2021 10.2450/2020.0128-20 Molecular basis of serological weak D phenotypes and RhD typing discrepancies identified in the Korean population Chung, YN; Kim, TY; Yu, HB; Bae, JC; Cho, D
    View PubMed
  • J CLIN APHERESIS 2021 10.1002/jca.21873 Initial experience with high-volume plasma exchange in patients with acute liver failure Kim1, JE; Chun, S; Sinn, DH; Kim, NJ; Kim, S; Kang, W; Kim, JM; Choi, GS; Joh, JW; Cho, D
    View PubMed
  • CELL MOL IMMUNOL 2021 10.1038/s41423-021-00686-9 Expanded natural killer cells augment the antimyeloma effect of daratumumab, bortezomib, and dexamethasone in a mouse model Thangaraj1, JL; Ahn, SY; Jung, SH; Vo, MC; Chu, TH; Phan, MTT; Kwon, M; Lee, KH; Kim, M; Song, GY; Yang, DH; Ahn, JS; Kim, HJ; Cho, D; Lee, JJ
    View PubMed
  • ACS SENSORS 2021 10.1021/acssensors.0c02138 Multifunctional Microparticles with Stimulation and Sensing Capabilities for Facile NK Cell Activity Assay Park1, J; Shin, Y; Kim, JM; Kweon, S; Song, AY; Baek, Y; Kim, J; Cho, D; Kim, HS; Doh, J
    View PubMed
  • ADV BIOL 2021 10.1002/adbi.202000195 Modeling 3D Human Tumor Lymphatic Vessel Network Using High-Throughput Platform Lee1, S; Kang, H; Park, D; Yu, J; Koh, SK; Cho, D; Kim, DH; Kang, KS; Jeon, NL
    View PubMed
  • TRANSPLANTATION 2021 10.1097/TP.0000000000003265 Decrease in the Risk of Posttransplant Hepatocellular Carcinoma Recurrence After the Conversion to Prestorage Leukoreduction for Transfused Red Blood Cells Kwon1, JH; Han, SB; Jang, JS; Lee, KW; Ahn, JH; Kim, K; Jeon, S; Gwak, MS; Ko, JS; Kim, GS; Joh, JW; Cho, D
    View PubMed
  • TRANSFUSION 2021 10.1111/trf.16233 The intronic variant RHD:c.149-29G > C designated as RHD*01EL.32 does not cause a DEL phenotype Kim1, TY; Yu, H; Cho, D
    View PubMed
  • BLOOD 2020 Avelumab for the treatment of relapsed or refractory extranodal NK/T-cell lymphoma an open-label phase 2 study Kim1, SJ; Lim, JQ; Laurensia, Y; Cho, J; Yoon, SE; Lee, JY; Ryu, KJ; Ko, YH; Koh, Y; Cho, D; Lim, ST; Enemark, MB; D'amore, F; Bjerre, M; Ong, CK; Kim, WS
    View PubMed
  • INT J LAB HEMATOL 2020 10.1111/ijlh.13396 Performance evaluation of platelet counting of Abbott Alinity hq and Sysmex XN-9000 automated hematology analyzer compared with international reference method Kim1, HY; Bang, SH; Cho, D; Kim, HJ; Kim, SH
    View PubMed
  • TRANSFUSION 2020 10.1111/trf.16033 The novel missense variant c.350G > T on the ABO*B.01 allele associated with a B-el phenotype Kim1, TY; Yu, H; Chung, YN; Jang, JH; Cho, D
    View PubMed
  • ANN LAB MED 2020 10.3343/alm.2020.40.5.409 Prevalence and Immunophenotypic Characteristics of Monoclonal B-Cell Lymphocytosis in Healthy Korean Individuals With Lymphocytosis Yoo1, IY; Bang, SH; Lim, DJ; Kim, SJ; Kim, K; Kim, HJ; Kim, SH; Cho, D
    View PubMed
  • INT J RADIAT ONCOL 2020 10.1016/j.ijrobp.2019.09.041 Combined NK Cell Therapy and Radiation Therapy Exhibit Long-Term Therapeutic and Antimetastatic Effects in a Human Triple Negative Breast Cancer Model Kim1, KW; Jeong, JU; Lee, KH; Uong, TNT; Rhee, JH; Ahn, SJ; Kim, SK; Cho, D; Nguyen, HPQ; Pham, CT; Yoon, MS
    View PubMed
  • TRANSFUS APHER SCI 2020 10.1016/j.transci.2020.102807 RHD genotyping is recommended for all patients with serological weak-D phenotypes in Asian populations - Cases with coexistence of weak-D and Asia type DEL alleles results in complete expression of D-antigen Chun1, S; Kim, H; Yun, JW; Yu, H; Seo, JY; Cho, D
    View PubMed
  • VOX SANG 2020 10.1111/vox.12944 Vox Sanguinis International Forum on Hospital Transfusion Services' Response to COVID-19 Responses Yazer1, MH; Jackson, B; Pagano, M; Rahimi-Levene, N; Peer, V; Bueno, JL; Jackson, RP; Shan, H; Amorim, L; Lopes, ME; Boquimpani, C; Sprogoe, U; Bruun, MT; Titlestad, K; Rushford, K; Wood, EM; McQuilten, ZK; de Angelis, V; Delle Donne, M; Murphy, M; Staves, J; Cho, D; Nakamura, F; Hangaishi, A; Callum, J; Lin, YL; Mogaddam, M; Gharehbaghian, A; Lozano, M
    View PubMed
  • FRONT IMMUNOL 2020 10.3389/fimmu.2020.01851 A Flow Cytometry-Based Whole Blood Natural Killer Cell Cytotoxicity Assay Using Overnight Cytokine Activation Kim1, J; Phan, MTT; Kweon, S; Yu, H; Park, J; Kim, KH; Hwang, I; Han, S; Kwon, MJ; Cho, D
    View PubMed
  • ANN LAB MED 2020 10.3343/alm.2020.40.4.337 First Korean Case of Partial D DBS-1 Choi1, S; Yu, H; Cho, D
    View PubMed
  • TRANSFUSION 2020 10.1111/trf.15908 A new RHD variant allele (RHD Gly339Val) shows weakened D expression compared to RHD Gly339Glu and Gly339Arg mutants Chun1, S; Lee, HJ; Cho, D
    View PubMed
  • EXP CLIN TRANSPLANT 2020 10.6002/ect.2018.0071 Infectious Complications in Patients Who Received High-Volume Plasma Exchange Prior to Liver Transplant: A Case Report Park1, GE; Peck, KR; Kim, JM; Kwon, CHD; Joh, JW; Cho, D; Sinn, DH
    View PubMed
  • ANN HEMATOL 2020 10.1007/s00277-020-04083-6 A comprehensive analysis of adult patients with secondary hemophagocytic lymphohistiocytosis: a prospective cohort study Yoon1, SE; Eun, Y; Huh, K; Chung, CR; Yoo, IY; Cho, J; Cho, D; Ko, YH; Park, S; Kim, WS; Kim, SJ
    View PubMed
  • ANN LAB MED 2020 10.3343/alm.2020.40.3.253 Isolation of Small Extracellular Vesicles From Human Serum Using a Combination of Ultracentrifugation With Polymer-Based Precipitation Ryu1, KJ; Lee, JY; Park, C; Cho, D; Kim, SJ
    View PubMed
  • PLoS One 2020 10.1371/journal.pone.0229724 Double-filtered leukoreduction as a method for risk reduction of transfusion-associated graft-versus-host disease Chun1, S; Phan, MTT; Hong, S; Yang, J; Yoon, Y; Han, S; Kang, J; Yazer, MH; Kim, J; Cho, D
    View PubMed
  • TRANSFUS APHER SCI 2020 10.1016/j.transci.2019.07.007 Clinical impact of massive transfusion protocol implementation in nontraumatic patients Yoon1, KW; Cho, D; Lee, DS; Gil, E; Yoo, K; Choi, KJ; Park, CM
    View PubMed
  • J CLIN MED 2020 10.3390/jcm9010147 Phase I Study of a B Cell-Based and Monocyte-Based Immunotherapeutic Vaccine, BVAC-C in Human Papillomavirus Type 16-or 18-Positive Recurrent Cervical Cancer Choi1, CH; Choi, HJ; Lee, JW; Kang, ES; Cho, D; Park, BK; Kim, YM; Kim, DY; Seo, H; Park, M; Kim, W; Choi, KY; Oh, T; Kang, CY; Kim, BG
    View PubMed
  • Ann Lab Med. 2019;39(1):102-104. Planned Transfusion of D-Positive Blood Components in an Asia Type DEL Patient: Proposed Modification of the Korean National Guidelines for Blood Transfusion. Choi S1, Chun S, Seo JY, Yang JH, Cho D*.
    View PubMed
  • Ann Lab Med. 2019;39(2):218-222. Red Blood Cell Alloimmunization in Korean Patients With Myelodysplastic Syndrome and Liver Cirrhosis. Kim HY1, Cho EJ, Chun S, Kim KH, Cho D*.
    View PubMed
  • Ann Lab Med. 2019;39(2):115-120. Cis-AB, the Blood Group of Many Faces, Is a Conundrum to the Novice Eye. Chun S1, Choi S, Yu H, Cho D*.
  • ANN LAB MED 2019 10.3343/alm.2019.39.6.602 First Case in Korea of a Patient With Anti-PP1Pk Antibodies: Successful Blood Management via Acute Normovolemic Hemodilution Ha1, C; Choi, S; Yu, H; Chun, S; Kim, KH; Lee, JH; Han, IW; Cho, D
    View PubMed
  • J CLIN APHERESIS 2019 10.1002/jca.21734 Single-dose etoposide is an effective and safe protocol for stem cell mobilization in patients with multiple myeloma Park1, Y; Kim, DS; Jeon, MJ; Lee, BH; Yu, ES; Kang, KW; Lee, SR; Sung, HJ; Nam, MH; Yoon, SY; Choi, CW; Kang, ES; Cho, D; Kim, K; Kim, BS; Kim, DW; Kim, SJ
    View PubMed
  • ANN LAB MED 2019 10.3343/alm.2019.39.5.430 Flow Cytometric Analysis of T Cells in Hemophagocytic Lymphohistiocytosis Park1, MS; Yoo, IY; Kim, HJ; Kim, SH; Kim, SJ; Cho, D
    View PubMed
  • KOREAN JOURNAL OF INTERNAL MEDICINE 2019 10.3904/kjim.2018.325 Cellular immunotherapy in multiple myeloma Vo1, MC; Lakshini, TJ; Jung, SN; Choi, D; Park, HS; Chu, TH; Lee, HJ; Kim, HJ; Kim, SK; Lee, JJ
    View PubMed
  • LEUKEMIA LYMPHOMA 2019 10.1080/10428194.2019.1573998 Analysis of circulating tumor DNA by targeted ultra-deep sequencing across various non-Hodgkin lymphoma subtypes Shin1, SH; Kim, YJ; Lee, D; Cho, D; Ko, YH; Cho, J; Park, WY; Park, D; Kim, SJ; Kim, WS
    View PubMed
  • Front Immunol 2019 10.3389/fimmu.2019.00879 Expansion of Human NK Cells Using K562 Cells Expressing OX40 Ligand and Short Exposure to IL-21 Kweonl1, S; Phan, MTT; Chun, S; Yu, H; Kim, J; Kim, S; Lee, J; Ali, AK; Lee, SH; Kim, SK; Doh, J; Cho, D
    View PubMed
  • ANN LAB MED 2019 10.3343/alm.2019.39.2.218 Red Blood Cell Alloimmunization in Korean Patients With Myelodysplastic Syndrome and Liver Cirrhosis Kim1, HY; Cho, EJ; Chun, S; Kim, KH; Cho, D
    View PubMed
  • ANN LAB MED 2019 10.3343/alm.2020.40.2.190 Extended Red Blood Cell Phenotype Matching Is Dependent on Ethnicity and Specificity of RBC Alloantibodies Kim1, HY; Chung, YN; Cho, D
    View PubMed
  • CANCER IMMUNOL RES 2019 10.1158/2326-6066.CIR-18-0317 An Antibody Designed to Improve Adoptive NK-Cell Therapy Inhibits Pancreatic Cancer Progression in a Murine Model Lee1, J; Kang, TH; Yoo, W; Choi, H; Jo, S; Kong, K; Lee, SR; Kim, SU; Kim, JS; Cho, D; Kim, J; Kim, JY; Kwon, ES; Kim, S
    View PubMed
  • ANN LAB MED 2019 10.3343/alm.2019.39.1.102 Planned Transfusion of D-Positive Blood Components in an Asia Type DEL Patient: Proposed Modification of the Korean National Guidelines for Blood Transfusion Choi1, S; Chun, S; Seo, JY; Yang, JH; Cho, D
    View PubMed
  • J CLIN LAB ANAL 2019 10.1002/jcla.22640 Association of neutrophil-to-lymphocyte ratio and natural killer cell activity revealed by measurement of interferon-gamma levels in a healthy population Kim1, BR; Chun, S; Cho, D; Kim, KH
    View PubMed
  • Anticancer Res. 2017;37(10):5507-5513. Effects of ADAM10 and ADAM17 Inhibitors on Natural Killer Cell Expansion and Antibody-dependent Cellular Cytotoxicity Against Breast Cancer Cells In Vitro. Pham DH1, Kim JS, Kim SK, Shin DJ, Uong NT, Hyun H, Yoon MS, Kang SJ, Ryu YJ, Cho JS, Yoon JH, Lee JS, Cho D, Lee SH, Park MH.
    View PubMed
  • Transfusion. 2018;58(11):2529-2537 Longer storage of red blood cells does not affect mortality in transfused liver transplant recipients. Kwon JH1, Han S, Cho D, Spahn DR, Ko JS, Kim DY, Jun JH, Gwak MS, Kim GS.
    View PubMed
  • Anticancer Res. 2018;38(10):5767-5772. X-ray as Irradiation Alternative for K562 Feeder Cell Inactivation in Human Natural Killer Cell Expansion. Kim GH1, Dang HN, Phan MT, Kweon SH, Chun S, Cho D*.
    View PubMed
  • J Clin Lab Anal. 2019 Jan;33(1):e22640. Association of neutrophil-to-lymphocyte ratio and natural killer cell activity revealed by measurement of interferon-gamma levels in a healthy population. Kim BR1, Chun S, Cho D*, Kim KH*.
    View PubMed
  • Ann Lab Med. 2018 Nov;38(6):585-590. Weak D Testing is not Required for D- Patients With C-E- Phenotype. Choi S1, Chun S, Lee HT, Yu H, Seo JY, Cho D*.
    View PubMed
  • Antivir Ther. 2018. doi: 10.3851/IMP3243 Challenges of convalescent plasma infusion therapy in Middle East respiratory coronavirus infection: a single centre experience. Ko JH1, Seok H, Cho SY, Ha YE, Baek JY, Kim SH, Kim YJ, Park JK, Chung CR, Kang ES, Cho D, M?ller MA, Drosten C, Kang CI, Chung DR, Song JH, Peck KR.
    View PubMed
  • J Clin Lab Anal. 2018;32(8):e22580 The first case of congenital blood chimerism in two of the triplets in Korea. Chung YN1, Chun S, Phan MT, Nam MH, Choi BM, Cho D, Choi JS.
    View PubMed
  • Front Immunol. 2018;9:841. doi: 10.3389/fimmu.2018.00841 Comparison of Phenotypic and Functional Characteristics Between Canine Non-B, Non-T Natural Killer Lymphocytes and CD3+CD5dimCD21- Cytotoxic Large Granular Lymphocytes. Lee SH1, Shin DJ, Kim Y, Kim CJ, Lee JJ, Yoon MS, Uong TNT, Yu D, Jung JY, Cho D, Jung BG, Kim SK, Suh GH.
    View PubMed
  • Cytotherapy. 2018;20(5):715-727. Effect of irradiation-induced intercellular adhesion molecule-1 expression on natural killer cell-mediated cytotoxicity toward human cancer cells. Jeong JU1, Uong TNT, Chung WK, Nam TK, Ahn SJ, Song JY, Kim SK, Shin DJ, Cho E, Kim KW, Cho D, Yoon MS.
    View PubMed
  • J Clin Lab Anal. 2018;32(4):e22330 The synonymous nucleotide substitution RHD 1056C>G alters mRNA splicing associated with serologically weak D phenotype. Chun S1, Yun JW, Park G*, Cho D*.
    View PubMed
  • Ann Surg. 2018;267(2):346-351 Perioperative Fresh Red Blood Cell Transfusion May Negatively Affect Recipient Survival After Liver Transplantation. Han S1, Kwon JH, Jung SH, Seo JY, Jo YJ, Jang JS, Yeon SM, Jung SH, Ko JS, Gwak MS, Cho D, Son HJ, Kim GS.
    View PubMed
  • TRANSFUSION 2018 10.1111/trf.14961 Longer storage of red blood cells does not affect mortality in transfused liver transplant recipients Kwon1, JH; Han, S; Cho, D; Spahn, DR; Ko, JS; Kim, DY; Jun, JH; Gwak, MS; Kim, GS
    View PubMed
  • ANN LAB MED 2018 10.3343/alm.2018.38.6.585 Weak D Testing is not Required for D- Patients With C-E- Phenotype Choi1, S; Chun, S; Lee, HT; Yu, H; Seo, JY; Cho, D
    View PubMed
  • ANTIVIR THER 2018 10.3851/IMP3243 Challenges of convalescent plasma infusion therapy in Middle East respiratory coronavirus infection: a single centre experience Ko1, JH; Seok, H; Cho, SY; Ha, YE; Baek, JY; Kim, SH; Kim, YJ; Park, JK; Chung, CR; Kang, ES; Cho, D; Muller, MA; Drosten, C; Kang, CI; Chung, DR; Song, JH; Peck, KR
    View PubMed
  • J CLIN LAB ANAL 2018 10.1002/jcla.22580 The first case of congenital blood chimerism in two of the triplets in Korea Chung1, YN; Chun, S; Phan, MTT; Nam, MH; Choi, BM; Cho, D; Choi, JS
    View PubMed
  • ANTICANCER RES 2018 10.21873/anticanres.12915 X-ray as Irradiation Alternative for K562 Feeder Cell Inactivation in Human Natural Killer Cell Expansion Kim1, GH; Dang, HN; Phan, MTT; Kweon, SH; Chun, S; Cho, D
    View PubMed
  • CYTOTHERAPY 2018 10.1016/j.jcyt.2018.01.010 Effect of irradiation-induced intercellular adhesion molecule-1 expression on natural killer cell-mediated cytotoxicity toward human cancer cells Jeong1, JU; Uong, TNT; Chung, WK; Nam, TK; Ahn, SJ; Song, JY; Kim, SK; Shin, DJ; Cho, E; Kim, KW; Cho, D; Yoon, MS
    View PubMed
  • J CLIN LAB ANAL 2018 10.1002/jcla.22330 The synonymous nucleotide substitution RHD L1056C > G alters mRNA splicing associated with serologically weak D phenotype Chun1, S; Yun, JW; Park, G; Cho, D
    View PubMed
  • Front Immunol 2018 10.3389/fimmu.2018.00841 Comparison of Phenotypic and Functional Characteristics Between Canine Non-B, Non-T Natural Killer Lymphocytes and CD3(+)CD5(dim)CD21(-)Cytotoxic Large Granular Lymphocytes Lee1, SH; Shin, DJ; Kim, Y; Kim, CJ; Lee, JJ; Yoon, MS; Uong, TNT; Yu, D; Jung, JY; Cho, D; Jung, BG; Kim, SK; Suh, GH
    View PubMed
  • ANN SURG 2018 10.1097/SLA.0000000000002062 Perioperative Fresh Red Blood Cell Transfusion May Negatively Affect Recipient Survival After Liver Transplantation Han1, S; Kwon, JH; Jung, SH; Seo, JY; Jo, YJ; Jang, JS; Yeon, SM; Jung, SH; Ko, JS; Gwak, MS; Cho, D; Son, HJ; Kim, GS
    View PubMed
  • TRANSFUS MED HEMOTH 2018 10.1159/000475506 ABO Mistyping of cis-AB Blood Group by the Automated Microplate Technique Chun1, S; Ryu, MR; Cha, SY; Seo, JY; Cho, D
    View PubMed
  • Transfus Apher Sci. 2017;56(3):427-430 Application of a portable microscopic cell counter for the counting of residual leukocytes in leukoreduced apheresis platelet concentrates in a hospital blood bank. Chun S1, Kim EY, Cha SY, Seo JY, Koo HH, Cho D.
    View PubMed
  • ANTICANCER RES 2017 10.21873/anticanres.11981 Effects of ADAM10 and ADAM17 Inhibitors on Natural Killer Cell Expansion and Antibody-dependent Cellular Cytotoxicity Against Breast Cancer Cells In Vitro Pham1, DH; Kim, JS; Kim, SK; Shin, DJ; Uong, NTT; Hyun, H; Yoon, MS; Kang, SJ; Ryu, YJ; Cho, JS; Yoon, JH; Lee, JS; Cho, D; Lee, SH; Park, MH
    View PubMed
  • Cancer Cell Int. 2017 Feb 10;17:22. doi: 10.1186/s12935-017-0397-7. eCollection 2017. Human U87 glioblastoma cells with stemness features display enhanced sensitivity to natural killer cell cytotoxicity through altered expression of NKG2D ligand Oh SJ11, Yang JI1, Kim O1, Ahn EJ2, Kang WD3, Lee JH1, Moon KS2, Lee KH1, Cho D4.
    View PubMed
  • Hum Immunol. 2017 Feb;78(2):103-112. doi: 10.1016/j.humimm.2016.11.006. Epub 2016 Nov 21. Natural killer cell subsets and receptor expression in peripheral blood mononuclear cells of a healthy Korean population: Reference range, influence of age and sex, and correlation between NK cell receptors and cytotoxicity Phan MT11, Chun S2, Kim SH2, Ali AK3, Lee SH3, Kim S4, Kim SH5, Cho D6.
    View PubMed
  • Ann Clin Lab Sci. 2017 Jan;47(1):99-102. The A312 Allele (c.280A > T) Is Responsible for the Weak A Phenotype Chun S11, Phan MT2, Kim HY1, Shin DJ3, Seo JY1, Kim KH4, Cho D5,6.
    View PubMed
  • Ann Lab Med 2016 Jul;36(4):335-41. Serious Adverse Transfusion Reactions Reported in the National Recipient-Triggered Trace Back System in Korea (2006-2014). Kwon JR1, Won EJ, Jo HJ, Choi SR, Lee K, Kim S, Ahn HS, Choi YS, Cho D, Lee DH.
    View PubMed
  • Ann Lab Med 2016 Jul;36(4):393-5. Possible Transfusion-Related Acute Lung Injury Following Convalescent Plasma Transfusion in a Patient With Middle East Respiratory Syndrome. Chun S1, Chung CR, Ha YE, Han TH, Ki CS, Kang ES, Park JK, Peck KR, Cho D.
    View PubMed
  • Vox Sang 2016 Aug 18, Protein stability changes of the novel p.Arg180Cys mutant A glycosyltransferase resulted in a weak A phenotype. Lee HS1, Choi KM, Won EJ, Thi Phan MT, Lee SY, Shin DJ, Chun S, Park G, Kim SK, Lee KB, Lee HJ, Cho D.
    View PubMed
  • Cytotherapy. 2016 Dec;18(12):1532-1542. doi: 10.1016/j.jcyt.2016.08.006. Epub 2016 Oct 6. Irradiation of breast cancer cells enhances CXCL16 ligand expression and induces the migration of natural killer cells expressing the CXCR6 receptor Yoon MS11, Pham CT2, Phan MT2, Shin DJ3, Jang YY4, Park MH5, Kim SK6, Kim S7, Cho D8.
    View PubMed
  • Vox Sang. 2016 Nov;111(4):441-444. doi: 10.1111/vox.12440. Epub 2016 Aug 18. Protein stability changes of the novel p.Arg180Cys mutant A glycosyltransferase resulted in a weak A phenotype Lee HS11, Choi KM2,3, Won EJ1, Thi Phan MT1,4, Lee SY5, Shin DJ6, Chun S2, Park G7, Kim SK6, Lee KB8, Lee HJ9, Cho D2.
    View PubMed
  • Vox Sang. 2016 Nov;111(4):425-430. doi: 10.1111/vox.12450. Epub 2016 Oct 19. An effective diagnostic strategy for accurate detection of RhD variants including Asian DEL type in apparently RhD-negative blood donors in Korea Seo MH11, Won EJ2, Hong YJ3, Chun S4, Kwon JR5, Choi YS5, Kim JN5, Lee SA6, Lim AH6, Kim SH7, Park KU3, Cho D4,8.
    View PubMed
  • Clin Lab. 2016 Oct 1;62(10):1995-2000. doi: 10.7754/Clin.Lab.2016.160320. Development of Real-time PCR and Melting Curve Analysis for the Rapid Detection of DEL with RHD (c.1222T > C) or RHD (c.1227G > A) Hong YJ1, Kim H, Song EY, Cho D, Park KU, Han KS.
    View PubMed
  • Ann Lab Med. 2016 Jul;36(4):393-5. doi: 10.3343/alm.2016.36.4.393. Possible Transfusion-Related Acute Lung Injury Following Convalescent Plasma Transfusion in a Patient With Middle East Respiratory Syndrome Chun S11, Chung CR2, Ha YE3, Han TH4, Ki CS1, Kang ES1, Park JK2, Peck KR5, Cho D6.
    View PubMed
  • Ann Lab Med. 2016 Jul;36(4):335-41. doi: 10.3343/alm.2016.36.4.335. Serious Adverse Transfusion Reactions Reported in the National Recipient-Triggered Trace Back System in Korea (2006-2014) Kwon JR11, Won EJ2, Jo HJ1, Choi SR1, Lee K3, Kim S4, Ahn HS5, Choi YS1, Cho D6, Lee DH7.
    View PubMed
  • Ann Lab Med. 2016 May;36(3):268-70. doi: 10.3343/alm.2016.36.3.268. Marked Increase of Circulating Double-Negative gamma delta T Cells in a Patient With Hydroa Vacciniforme-Like Lymphoma Shin SY11, Park CH1, Cho D1, Kim HJ1, Kim SH2.
    View PubMed
  • Vet Microbiol. 2015 Apr 17;176(3-4):239-49. doi: 10.1016/j.vetmic.2015.01.021. Epub 2015 Feb 3. The anti-canine distemper virus activities of ex vivo-expanded canine natural killer cells. Park JY11, Shin DJ2, Lee SH2, Lee JJ3, Suh GH4, Cho D5, Kim SK6.
    View PubMed
  • Ann Lab Med. 2015 Jul;35(4):423-8. doi: 10.3343/alm.2015.35.4.423. Epub 2015 May 21. Comparison of FcRγ-Deficient and CD57+ Natural Killer Cells Between Cord Blood and Adult Blood in the Cytomegalovirus-Endemic Korean Population. Baek HJ11, Kim DW2, Phan MT3, Kim JS4, Yang JH5, Choi JI5, Lee JJ4, Shin MG6, Ryang DW6, Kim SK7, Lee SH8, Kook H1, Cho D3.
    View PubMed
  • Transfus Med. 2015 Oct;25(5):333-6. doi: 10.1111/tme.12229. Epub 2015 Jul 22. A novel cis-AB variant allele arising from a de novo nucleotide substitution c.796A>G (p.M266V) in the B glycosyltransferase gene. Lee SY11, Phan MT1,2, Shin DJ1,3, Shin MG1, Park JT4, Shin JW5, Yazer MH6,7, Shin HB8, Cho D9.
    View PubMed
  • Transfus Med. 2015 Oct;25(5):333-6. doi: 10.1111/tme.12229. Epub 2015 Jul 22. A novel cis-AB variant allele arising from a de novo nucleotide substitution c.796A > G (p.M266V) in the B glycosyltransferase gene Lee SY11, Phan MT1,2, Shin DJ1,3, Shin MG1, Park JT4, Shin JW5, Yazer MH6,7, Shin HB8, Cho D9.
    View PubMed
  • Ann Lab Med. 2015 Sep;35(5):554-6. doi: 10.3343/alm.2015.35.5.554. Primary Anti-D Alloimmunization Induced by "Asian Type" RHD (c.1227G > A) DEL Red Cell Transfusion Yang HS11, Lee MY1, Park TS2, Cho SY1, Lee HJ1, Lim G3, Lee DD4, Oh SH5, Cho D6, Park KU7.
    View PubMed
  • Vet Immunol Immunopathol. 2015 May 15;165(1-2):22-33. doi: 10.1016/j.vetimm.2015.03.004. Epub 2015 Mar 13. Interleukin-21 induces proliferation and modulates receptor expression and effector function in canine natural killer cells Shin DJ11, Lee SH2, Park JY1, Kim JS2, Lee JJ3, Suh GH4, Lee YK3, Cho D5, Kim SK6.
    View PubMed
  • Cytotherapy. 2014 Oct;16(10):1419-30. doi: 10.1016/j.jcyt.2014.04.008. Epub 2014 Jun 18. Effect of exposure to interleukin-21 at various time points on human natural killer cell culture. Lim DP11, Jang YY2, Kim S3, Koh SS3, Lee JJ2, Kim JS4, Thi Phan MT5, Shin DJ6, Shin MG7, Lee SH8, Yoon M9, Kim SK4, Yoon JH1, Park MH10, Cho D11.
    View PubMed
  • Transfusion. 2014 May;54(5):1298-304. doi: 10.1111/trf.12461. Epub 2013 Oct 28. The p.R168Q mutation is associated with the Bw phenotype and a predicted decrease in the stability of the resulting ABO glycosyltransferase. Lee SY11, Ihm C, Shin DJ, Lee HJ, Yazer MH, Kim SY, Shin MG, Shin JH, Suh SP, Ryang DW, Cho D.
    View PubMed
  • Tissue Antigens. 2014 Jan;83(1):61-3. doi: 10.1111/tan.12246. Epub 2013 Nov 7. A new HLA-C allele, C*06:99, identified by sequence-based typing in a Korean individual. Kim SH11, Yoon CE, Kwon OJ, Cho D, Shin MG.
    View PubMed
  • Ann Lab Med. 2014 May;34(3):259-62. doi: 10.3343/alm.2014.34.3.259. Epub 2014 Apr 8. The first known case of blood group chimerism in monochorionic dizygotic twins in Korea. Lee OJ11, Cho D1, Shin MG1, Kim SO2, Park JT3, Kim HK4, Ryang DW1.
    View PubMed
  • Ann Lab Med. 2013 Sep;33(5):343-8. doi: 10.3343/alm.2013.33.5.343. Epub 2013 Aug 8. Autoantibodies with mimicking specificity detected by the dilution technique in patients with warm autoantibodies. Jang MJ11, Cho D, Park KU, Yazer MH, Shin MG, Shin JH, Suh SP, Ryang DW.
    View PubMed
  • J Clin Pathol. 2013 May;66(5):446-8. doi: 10.1136/jclinpath-2012-201355. Epub 2013 Feb 15. Amplification refractory mutation system-PCR is essential for the detection of chimaeras with a minor allele population: a case report. Won EJ11, Park HR, Park TS, Oh SH, Shin MG, Shin JH, Suh SP, Ryang DW, Park JT, Cho D.
    View PubMed
  • Anticancer Res. 2013 May;33(5):2011-9. Ex vivo expansion of natural killer cells using cryopreserved irradiated feeder cells. Baek HJ11, Kim JS, Yoon M, Lee JJ, Shin MG, Ryang DW, Kook H, Kim SK, Cho D.
    View PubMed
  • Vet Immunol Immunopathol. 2013 Jun 15;153(3-4):249-59. doi: 10.1016/j.vetimm.2013.03.006. Epub 2013 Mar 21. Ex vivo expansion of canine cytotoxic large granular lymphocytes exhibiting characteristics of natural killer cells. Shin DJ11, Park JY, Jang YY, Lee JJ, Lee YK, Shin MG, Jung JY, Carson WE 3rd, Cho D, Kim SK.
    View PubMed
  • Gastric Cancer. 2013 Apr;16(2):254-60. doi: 10.1007/s10120-012-0176-z. Epub 2012 Aug 3. Sex-specific differences in the association between ABO genotype and gastric cancer risk in a Korean population. Song HR11, Shin MH, Kim HN, Piao JM, Choi JS, Hwang JE, Park YK, Ryang DW, Cho D, Kweon SS.
    View PubMed
  • Anticancer Res. 2013 Jun;33(6):2525-33. Immunological characterization of glioblastoma cells for immunotherapy. Jung TY11, Choi YD, Kim YH, Lee JJ, Kim HS, Kim JS, Kim SK, Jung S, Cho D.
    View PubMed
  • Anticancer Res. 2012 Mar;32(3):839-46. Interleukin-21 increases direct cytotoxicity and IFN-γ production of ex vivo expanded NK cells towards breast cancer cells. Park YK11, Shin DJ, Cho D, Kim SK, Lee JJ, Shin MG, Ryang DW, Lee JS, Park MH, Yoon JH, Jegal YJ.
    View PubMed
  • Ann Clin Lab Sci. 2012 Winter;42(1):42-9. An improved flow cytometry-based natural killer cytotoxicity assay involving calcein AM staining of effector cells. Jang YY11, Cho D, Kim SK, Shin DJ, Park MH, Lee JJ, Shin MG, Shin JH, Suh SP, Ryang DW.
    View PubMed
  • Tissue Antigens. 2012 Oct;80(4):384-5. doi: 10.1111/j.1399-0039.2012.01937.x. Epub 2012 Aug 4. A new HLA-C*07:244 allele identified by sequence-based typing in a Korean individual. Cho D11, Jang MJ, Yoon CE, Kwon OJ, Shin MG.
    View PubMed
  • Tissue Antigens. 2012 May;79(5):384-5. doi: 10.1111/j.1399-0039.2012.01847.x. Epub 2012 Feb 13. HLA-A*02:07:02, a new allele identified by sequence-based typing in a Korean individual. Cho D11, Won EJ, Yoon CE, Kwon OJ, Shin MG.
    View PubMed
  • Ann Clin Lab Sci. 2011 Summer;41(3):282-4. A novel a subtype allele that demonstrates allelic competition. Kim DW11, Cho D, Yazer MH, Lee HJ, Kim KH, Shin MG, Suh SP, Shin JH, Ryang DW.
    View PubMed
  • Clin Cancer Res. 2010 Aug 1;16(15):3901-9. doi: 10.1158/1078-0432.CCR-10-0735. Epub 2010 Jun 11. Cytotoxicity of activated natural killer cells against pediatric solid tumors. Cho D11, Shook DR, Shimasaki N, Chang YH, Fujisaki H, Campana D.
    View PubMed
  • Korean J Lab Med. 2010 Feb;30(1):65-9. doi: 10.3343/kjlm.2010.30.1.65. The M142T mutation causes B3 phenotype: three cases and an in vitro expression study. Cho D11, Shin DJ, Yazer MH, Ihm CH, Hur YM, Kee SJ, Kim SH, Shin MG, Shin JH, Suh SP, Ryang DW
    View PubMed